Gill Riley, from Warrington, Cheshire, started using the weight-loss injections, which work by mimicking hormones that ...
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...
With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...
The challenge of the obesity epidemic is widespread and one that even pediatricians face constantly,” a Connecticut doctor ...
Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.
China’s obesity crisis is a sizeable profit opportunity. More than half of Chinese adults are overweight or obese — a figure expected to hit two-thirds by 2030. That is nearly 900mn people, a market ...
In the latest research, scientists from Canada tracked nearly 3,000 Americans who used either semaglutide, the active drug in ...
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results